Logo image of ASPS

ALTISOURCE PORTFOLIO SOL (ASPS) Stock Fundamental Analysis

NASDAQ:ASPS - Nasdaq - LU0445408270 - Common Stock - Currency: USD

8.1  +0.2 (+2.53%)

Fundamental Rating

2

Overall ASPS gets a fundamental rating of 2 out of 10. We evaluated ASPS against 65 industry peers in the Real Estate Management & Development industry. ASPS may be in some trouble as it scores bad on both profitability and health. ASPS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ASPS has reported negative net income.
In the past year ASPS has reported a negative cash flow from operations.
ASPS had negative earnings in 4 of the past 5 years.
ASPS had a negative operating cash flow in each of the past 5 years.
ASPS Yearly Net Income VS EBIT VS OCF VS FCFASPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

The Return On Assets of ASPS (-21.82%) is worse than 75.38% of its industry peers.
With an excellent Return On Invested Capital value of 5.82%, ASPS belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
Industry RankSector Rank
ROA -21.82%
ROE N/A
ROIC 5.82%
ROA(3y)-29.51%
ROA(5y)-21.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPS Yearly ROA, ROE, ROICASPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

Looking at the Operating Margin, with a value of 4.69%, ASPS is in the better half of the industry, outperforming 67.69% of the companies in the same industry.
ASPS's Operating Margin has improved in the last couple of years.
ASPS's Gross Margin of 30.80% is in line compared to the rest of the industry. ASPS outperforms 56.92% of its industry peers.
ASPS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.69%
PM (TTM) N/A
GM 30.8%
OM growth 3YN/A
OM growth 5Y1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y98.22%
GM growth 5Y5.24%
ASPS Yearly Profit, Operating, Gross MarginsASPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASPS is destroying value.
The number of shares outstanding for ASPS has been increased compared to 1 year ago.
The number of shares outstanding for ASPS has been increased compared to 5 years ago.
Compared to 1 year ago, ASPS has a worse debt to assets ratio.
ASPS Yearly Shares OutstandingASPS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ASPS Yearly Total Debt VS Total AssetsASPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ASPS has an Altman-Z score of -0.48. This is a bad value and indicates that ASPS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.48, ASPS is doing worse than 73.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACC0.74
WACC7.86%
ASPS Yearly LT Debt VS Equity VS FCFASPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ASPS has a Current Ratio of 1.30. This is a normal value and indicates that ASPS is financially healthy and should not expect problems in meeting its short term obligations.
ASPS has a Current ratio of 1.30. This is comparable to the rest of the industry: ASPS outperforms 49.23% of its industry peers.
A Quick Ratio of 1.30 indicates that ASPS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.30, ASPS perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
ASPS Yearly Current Assets VS Current LiabilitesASPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

ASPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.93%, which is quite impressive.
Looking at the last year, ASPS shows a quite strong growth in Revenue. The Revenue has grown by 13.12% in the last year.
The Revenue for ASPS have been decreasing by -24.41% on average. This is quite bad
EPS 1Y (TTM)70.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)13.12%
Revenue growth 3Y-3.55%
Revenue growth 5Y-24.41%
Sales Q2Q%3.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y94.62%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASPS Yearly Revenue VS EstimatesASPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ASPS Yearly EPS VS EstimatesASPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ASPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ASPS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPS Price Earnings VS Forward Price EarningsASPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASPS is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.77
ASPS Per share dataASPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTISOURCE PORTFOLIO SOL

NASDAQ:ASPS (6/11/2025, 8:00:01 PM)

8.1

+0.2 (+2.53%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-21 2025-07-21
Inst Owners33.86%
Inst Owner Change348.79%
Ins Owners27.32%
Ins Owner Change58.56%
Market Cap709.48M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio11.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.32
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 56.77
EPS(TTM)-5.14
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.87
BVpS-1.37
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.82%
ROE N/A
ROCE 7.44%
ROIC 5.82%
ROICexc 8.26%
ROICexgc N/A
OM 4.69%
PM (TTM) N/A
GM 30.8%
FCFM N/A
ROA(3y)-29.51%
ROA(5y)-21.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y1.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y98.22%
GM growth 5Y5.24%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 12.65
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z -0.48
F-Score5
WACC7.86%
ROIC/WACC0.74
Cap/Depr(3y)2.56%
Cap/Depr(5y)5.32%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y94.62%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.12%
Revenue growth 3Y-3.55%
Revenue growth 5Y-24.41%
Sales Q2Q%3.63%
Revenue Next Year33.86%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y156.11%
EBIT growth 3YN/A
EBIT growth 5Y-22.96%
EBIT Next Year468.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75%
OCF growth 3YN/A
OCF growth 5YN/A